COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Use of Barbed Sutures in Total Hip Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02609464
Recruitment Status : Unknown
Verified May 2017 by Rothman Institute Orthopaedics.
Recruitment status was:  Enrolling by invitation
First Posted : November 20, 2015
Last Update Posted : May 18, 2017
Ethicon, Inc.
Information provided by (Responsible Party):
Rothman Institute Orthopaedics

Brief Summary:
The purpose of this study is to evaluate the role of new barbed suture for closure of wound during total hip arthroplasty in reducing the risk for wound healing problems.

Condition or disease Intervention/treatment Phase
Osteoarthritis, Hip Device: Interrupted Knotted Sutures Device: STRATAFIX Symmetric PDS PLUS Knotless Tissue Control Devices Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Official Title: The Use of Barbed Sutures in Total Hip Arthroplasty: A Prospective, Randomized, and Controlled Clinical Trial
Study Start Date : December 2015
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : January 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Inturrupted Knotte Sutures Device: Interrupted Knotted Sutures
Active Comparator: Barbed Sutures Device: STRATAFIX Symmetric PDS PLUS Knotless Tissue Control Devices

Primary Outcome Measures :
  1. Incidence of suture abscess or other wound related compilation [ Time Frame: Within 30 days of surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion criteria:

  • All patients receiving elective primary THA through the direct anterior approach, treated by the primary investigator (JP) at the Thomas Jefferson University Hospital or Rothman Specialty Hospital.

Exclusion Criteria:

  • Prior surgical incision or scar in close proximity of the proposed incision (<2 cm).
  • Local skin conditions such as dermatitis, eczema, or psoriasis.
  • Active or previous infection in the skin or the hip.
  • Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical cortico-steroid use

Layout table for additonal information
Responsible Party: Rothman Institute Orthopaedics Identifier: NCT02609464    
Other Study ID Numbers: 15P01
First Posted: November 20, 2015    Key Record Dates
Last Update Posted: May 18, 2017
Last Verified: May 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoarthritis, Hip
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases